Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-09
2010-06-29
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S252020, C514S254050, C514S256000, C544S122000, C544S238000, C544S295000, C544S328000
Reexamination Certificate
active
07745437
ABSTRACT:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, PDGF-R, trkB, c-SRC, BMX, FGFR3, b-RAF, ΣΓK, Tιε2, Λχκ, θNK2α2, MKK4, c-RAF, MKK6, SAPK2α and SAPK2β kinases.
REFERENCES:
patent: 6747031 (2004-06-01), Arnaiz et al.
Ulrich, Chapter 4:Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Vippagunta et al., Crystalline Solids, Advanced Drug Deliversy Reviews, 48, pp. 3-26, 2001.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Traxler, Protein Tyrosine Kinase Inhibitors in cancer treatment, Expert Opinion on Therapeutic Patents, 7(6):571-588, 1997.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Albaugh Pamela A.
Chopiuk Greg
Ding Qiang
Gray Nathanael Schiander
Ren Pingda
Genomics Institute of the Novartis Research Foundation
IRM LLC
Rao Deepak
Reid Scott W.
LandOfFree
Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236582